Clinical trial
Comparison of Intradermal Microinjections of Tanexamic Acid and Oral Tranexamic Acid in the Management of Melasma. A Randomized Controlled Trial.
NCT07280234 is registered in ClinicalTrials.gov with Hayat Abad Medical Complex, Peshawar as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Intradermal Microinjections of Tanexamic Acid and Oral Tranexamic Acid in the Management of Melasma. A Randomized Controlled Trial.
- Lead sponsor
- Hayat Abad Medical Complex, Peshawar
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 14, 2024
- Completion date
- May 15, 2025
- Enrollment
- 218 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
melasma